← Amphastar Pharmaceuticals, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $72.4m | $65.6m | $86.3m | $73.7m | $92.6m | $126.4m | $156.1m | $144.3m | $151.6m | $170.2m | |
| Prepaid Expense and Other Assets, Current | $3.3m | $9.8m | $5.5m | $9.5m | $6.8m | $7.3m | $7.6m | $9.1m | $18.2m | $13.2m | |
| Restricted Cash and Investments, Current | — | $4.2m | $4.2m | — | — | — | — | — | — | — | |
| Short-term Investments | $527k | $2.6m | $2.8m | $11.7m | $13.0m | $10.3m | $19.7m | $112.5m | $70.0m | $112.6m | |
| Inventory, Net | $79.8m | $63.6m | $69.3m | $110.5m | $96.8m | $92.8m | $103.6m | $105.8m | $153.7m | $176.9m | |
| Assets, Current | $184.1m | $187.8m | $220.3m | $255.2m | $279.7m | $318.1m | $378.3m | $489.6m | $534.1m | $636.0m | |
| Property, Plant and Equipment, Net | $152.9m | $185.3m | $210.4m | $233.9m | $260.1m | $244.2m | $238.3m | $282.7m | $297.3m | $310.6m | |
| Goodwill | $4.0m | $4.5m | $4.0m | $3.6m | $3.9m | $3.3m | $3.1m | $3.2m | $3.0m | $3.4m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $18.8m | $20.0m | $26.9m | $25.6m | $32.3m | $46.9m | $42.9m | |
| Other Assets, Noncurrent | $9.4m | $8.7m | $9.9m | $11.2m | $5.2m | $16.7m | $20.9m | $25.9m | $26.0m | $31.1m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $26.8m | $36.0m | $52.2m | $45.4m | $66.0m | $78.8m | $88.8m | $114.9m | $136.3m | $143.6m | |
| Accrued Liabilities, Current | $15.7m | $40.9m | $56.1m | $52.0m | $71.1m | $67.3m | $63.7m | $67.9m | $126.5m | $115.8m | |
| Assets | $427.7m | $454.7m | $513.6m | $587.0m | $631.2m | $671.5m | $742.0m | $1.5b | $1.6b | $1.6b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $3.2m | $3.4m | $3.0m | $3.0m | $3.9m | $6.8m | $7.9m | |
| Accounts Payable, Current | $16.2m | $16.6m | $31.3m | $25.1m | $24.4m | $22.2m | $20.5m | $25.4m | $30.5m | $32.6m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $16.3m | $17.5m | $24.7m | $23.7m | $29.7m | $41.9m | $37.7m | |
| Deferred Revenue, Noncurrent | $97k | — | — | — | — | — | — | — | — | — | |
| Long-term Debt, Excluding Current Maturities | $36.0m | $45.7m | $49.1m | $46.3m | $45.9m | $78.2m | $76.6m | $603.2m | $613.5m | $619.7m | |
| Liabilities, Current | $60.6m | $67.2m | $106.8m | $90.0m | $112.2m | $103.8m | $94.9m | $225.4m | $173.8m | $158.2m | |
| Deferred Income Tax Liabilities, Net | $845k | $879k | $415k | $867k | $741k | $534k | $144k | $6.1m | — | $5.9m | |
| Other Liabilities, Noncurrent | $1.8m | $7.1m | $8.9m | $9.4m | $13.2m | $15.7m | $14.6m | $22.7m | $20.9m | $30.0m | |
| Liabilities | $98.5m | $117.3m | $149.2m | $159.4m | $182.5m | $226.0m | $213.3m | $873.5m | $845.2m | $840.5m | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $5k | $5k | $5k | $5k | $5k | $6k | $6k | $6k | $6k | $6k | |
| Additional Paid in Capital | $283.1m | $313.9m | $344.4m | $367.3m | $410.1m | $422.4m | $455.1m | $486.1m | $505.4m | $535.4m | |
| Retained Earnings (Accumulated Deficit) | $70.9m | $76.2m | $67.5m | $116.4m | $117.8m | $180.3m | $271.7m | $409.3m | $568.8m | $666.9m | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($4.7m) | ($2.1m) | ($4.0m) | ($4.7m) | ($3.7m) | ($6.8m) | ($8.6m) | ($8.5m) | ($9.2m) | ($5.3m) | |
| Stockholders' Equity Attributable to Parent | $329.3m | $337.3m | $332.4m | $381.4m | $402.3m | $445.5m | — | — | — | — | |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | — | $31.9m | $46.2m | $46.4m | — | — | — | — | — | |
| Liabilities and Equity | $427.7m | $454.7m | $513.6m | $587.0m | $631.2m | $671.5m | $742.0m | $1.5b | $1.6b | $1.6b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.